DocketNumber: 16-193
Judges: Nora Beth Dorsey
Filed Date: 4/2/2020
Status: Non-Precedential
Modified Date: 4/2/2020
In the United States Court of Federal Claims OFFICE OF SPECIAL MASTERS Filed: February 25, 2020 * * * * * * * * * * * * * * * * * * * MELISSA FRANKLIN, * UNPUBLISHED * * No. 16-193V Petitioner, * * Special Master Dorsey v. * * Decision Based on Stipulation; SECRETARY OF HEALTH * Measles, Mumps, and Rubella AND HUMAN SERVICES, * Vaccine (“MMR”); Tetanus- * Diphtheria-Acellular Pertussis Respondent. * (“Tdap”) Vaccine; Transverse * Myelitis (“TM”). * * * * * * * * * * * * * * * * * * * Ron C. Homer, Conway, Homer, P.C., Boston, MA, for petitioner. Adriana R. Teitel, US Department of Justice, Washington, DC, for respondent. DECISION BASED ON STIPULATION1 On February 8, 2016, Melissa Franklin (“petitioner”) filed a petition in the National Vaccine Injury Compensation Program.2 Petitioner alleged that as a result of the Measles, Mumps, and Rubella (“MMR”) and Tetanus-diphtheria-acellular pertussis (“Tdap”) vaccinations administered to her on April 18, 2014, petitioner suffered from transverse myelitis (“TM”). Petition at 1. 1 Because this Decision contains a reasoned explanation for the action in this case, the undersigned is required to post it on the United States Court of Federal Claims’ website in accordance with the E-Government Act of 2002.44 U.S.C. § 3501
note (2012) (Federal Management and Promotion of Electronic Government Services). This means the Decision will be available to anyone with access to the Internet. In accordance with Vaccine Rule 18(b), petitioner has 14 days to identify and move to redact medical or other information, the disclosure of which would constitute an unwarranted invasion of privacy. If, upon review, the undersigned agrees that the identified material fits within this definition, the undersigned will redact such material from public access. 2 The National Vaccine Injury Compensation Program is set forth in Part 2 of the National Childhood Vaccine Injury Act of 1986, Pub. L. No. 99-660,100 Stat. 3755
, codified as amended, 42 U.S.C. §§ 300aa-1 to -34 (2012) (“Vaccine Act” or “the Act”). All citations in this decision to individual sections of the Vaccine Act are to 42 U.S.C. § 300aa. 1 On February 25, 2020, the parties filed a stipulation recommending an award of compensation to petitioner. Stipulation (ECF No. 63). Respondent denies that the MMR and Tdap vaccines administered on or about April 18, 2014 caused petitioner’s TM, or any other injury. Nevertheless, the parties agree to the joint stipulation, attached hereto as Appendix A. The undersigned finds the stipulation reasonable and adopts it as the decision of the Court in awarding damages, on the terms set forth therein. The parties stipulate that petitioner shall receive the following compensation: (1) A lump sum of $400,000.00 in the form of a check payable to petitioner; This amount represents compensation for first year life care expenses ($25,000.00) and combined lost earnings, pain and suffering, and past reimbursable expenses ($375,000.00). (2) A lump sum of $189,137.87, representing reimbursement of a State of California Medicaid lien for services rendered on behalf of petitioner, Melissa Franklin, in the form of a check payable jointly to petitioner and: Department of Health Care Services Recovery Branch – MS 4720 P.O. Box 997421 Sacramento, CA 95899-7421 DHCS Account No.: C92766561A-VAC03 Petitioner agrees to endorse this payment to California Medicaid; and (3) An amount sufficient to purchase the annuity contract described in paragraph 10 of the stipulation, attached as Appendix A, paid to the life insurance company from which the annuity will be purchased (the “Life Insurance Company”). These amounts represent compensation for all damages that would be available under 42 U.S.C. § 300aa-15(a). The undersigned approves the requested amount for petitioners’ compensation. Accordingly, an award should be made consistent with the stipulation. In the absence of a motion for review filed pursuant to RCFC Appendix B, the Clerk of Court SHALL ENTER JUDGMENT in accordance with the terms of the parties’ stipulation.3 IT IS SO ORDERED. s/Nora B. Dorsey Nora B. Dorsey Special Master 3 Pursuant to Vaccine Rule 11(a), entry of judgment is expedited by the parties’ joint filing of notice renouncing the right to seek review. 2